THE DEFINITIVE GUIDE TO AZELAPRAG AMGEN

AMG 986 exposures improved nonlinearly with increasing doses; minimum accumulation was noticed. In HF with reduced ejection fraction clients, there have been numerical improves in % changes from baseline in LV ejection fraction and stroke volume by volumetric assessment with AMG 986 vs placebo (stroke quantity maximize not recapitulated by Doppler)